TrialSignal transduction and targeted therapy2022

Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial.

Xiaoying Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.